Topic: Mylan

11Jul/18

Mylan Launches Generic Version Of The Novartis Exelon Patch

Mylan N.V.¬†today announced the U.S. launch of Rivastigmine Transdermal System, 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, a generic version of Novartis’ Exelon Patch. Mylan received final approval fromRead More…